invicro.com is a domain that was created on 2008-04-02,making it 16 years ago. It has several subdomains, such as blog.invicro.com , among others.
Discover invicro.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 88.123 KB |
Page Load Time: 0.549297 Seconds |
Website IP Address: 141.193.213.10 |
Invicro: Home https://invicro.com/ |
Subscribe https://invicro.com/subscribe/ |
Capabilities https://invicro.com/capabilities/ |
Contact https://invicro.com/contact/ |
Resources https://invicro.com/resources/ |
About https://invicro.com/about/ |
Solutions https://invicro.com/solutions/ |
sescher, Author at Invicro https://invicro.com/author/sescher/ |
Events https://invicro.com/about/events/ |
Molecular & Functional Imaging in Early Phase Drug ... https://lp.invicro.com/july18 |
A invicro.com. 60 IN A 141.193.213.11 |
MX invicro.com. 300 IN MX 10 mxb-00501c01.gslb.pphosted.com. |
NS invicro.com. 300 IN NS ns1.first-ns.de. |
TXT invicro.com. 300 IN TXT atlassian-domain-verification=tun93WHhmu9DmaDdP9UqZ0RO3LsLMBtfdByhSMaQbH7qgnJOvYo4jTRsTSlhIset |
SOA invicro.com. 300 IN SOA ns1.first-ns.de. dns.hetzner.com. 2024050701 14400 1800 604800 300 |
Date: Mon, 13 May 2024 15:42:20 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
Link: https://invicro.com/wp-json/; rel="https://api.w.org/", https://invicro.com/wp-json/wp/v2/pages/20; rel="alternate"; type="application/json", https://invicro.com/; rel=shortlink |
X-Powered-By: WP Engine |
X-Cacheable: SHORT |
Cache-Control: max-age=600, must-revalidate |
X-Cache: HIT: 4 |
X-Cache-Group: normal |
CF-Cache-Status: DYNAMIC |
Server: cloudflare |
CF-RAY: 8833c1fefa782f57-LAX |
alt-svc: h3=":443"; ma=86400 |
charset="utf-8"/ |
content="ie=edge" http-equiv="x-ua-compatible"/ |
content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots" |
content="en_US" property="og:locale" |
content="website" property="og:type" |
content="Home - Invicro" property="og:title"/ |
content="https://invicro.com/" property="og:url"/ |
content="Invicro" property="og:site_name"/ |
content="https://www.facebook.com/invicro/" property="article:publisher"/ |
content="2024-05-01T12:02:35+00:00" property="article:modified_time"/ |
content="summary_large_image" name="twitter:card"/ |
content="@Invicro" name="twitter:site"/ |
content="https://invicro.com/wp-content/uploads/2023/10/cropped-invicro_logo_2023_favicon-270x270.png" name="msapplication-TileImage"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
Solutions Solutions Invicro’s quantitative biomarkers, advanced analytics and imaging solutions enhances the discovery and development of life-changing drugs. Drug Discovery Early Clinical Late Phase PSMA-PET Radiopharmaceutical Therapy & Theranostics Therapeutic Areas Therapeutic Areas Invicro’s medical imaging capabilities, experience, and expertise span several therapeutic areas. Oncology Central Nervous System Respiratory Areas of Growth Capabilities Capabilites Invicro serves top pharma and biotech companies from molecular discovery through late-phase clinical trials. Preclinical Imaging Early Clinical Imaging Clinical Imaging Core Lab Radiochemistry Image Analysis Software About About Invicro solves drug development problems through the Design, Capture, Analysis and Management of data. Leadership News Events Careers Sites & Partners Resources Resources Enjoy complimentary access to market insights and trends, including publications, case studies, informative webinars and more. Webinars Publications Case Studies Contact Subscribe A Truly Differentiated Imaging Leader for the Global Clinical Research Community Learn More Complete Radiopharmaceutical Therapy Solutions Learn More Complete Clinical Imaging Core Lab Capabilities Learn More Unmatched PSMA-PET Solutions: Advancing the Standard of Care Learn More Learn What Invicro’s IQ Analytics Platform Can Do Learn More Gain New Insights in Early Drug Discovery Learn More SNMMI Annual Meeting 2024 Stop by booth #1822 to discover how our comprehensive imaging solutions can elevate your research endeavors. At Invicro, we specialize in providing cutting-edge scientific and operational expertise tailored to meet the unique needs of preclinical and clinical projects across various therapeutic areas and modalities . Let’s Chat Premier Bioluminescence Imaging Services Invicro has made a profound impact in the field of bioluminescence imaging (BLI) research for our pharma partners with our leadership being the first to bring this disrupting technology into the CRO space. The speed & precision of our image analytics and reporting, coupled with highly performing deep tissue tumor models has allowed us to stay at the forefront of this imaging modality. Contact us to discuss BLI driven PK/PD or efficacy studies. Let’s Chat SUPPORTING ALL DRUG DISCOVERY & DEVELOPMENT PHASES DRUG DISCOVERY EARLY CLINICAL LATE PHASE THERAPEUTIC AREA EXPERTISE ONCOLOGY CENTRAL NERVOUS SYSTEM RESPIRATORY AREAS OF GROWTH Core Capabilities Preclinical Imaging Early Clinical Imaging Clinical Imaging Core Lab Pathology Radiochemistry Image Analysis Software 3,500+ Research Trials Managed 535+ Clinical Trials Managed 40,000,000+ (DICOM) Images Processed 800+ Molecules Labeled CNS Webinar Series Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials. Watch Now Oncology Webinar Series Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies. Watch Now Solutions Drug Discovery Early Clinical Late Phase PSMA-PET Radiopharmaceutical Therapy & Theranostics Therapeutic Areas Oncology Central Nervous System Respiratory Areas of Growth Capabilities Preclinical Imaging Early Clinical Imaging Clinical Imaging Core Lab Pathology Services Radiochemistry Image Analysis Software About Leadership News Events Careers Sites & Partners Resources Webinars Publications Case Studies Contact Cookie Notice Privacy Notice Terms of Use FCOI Policy Drug Phase Solutions Drug Discovery Translational/Early Phase Late Phase Therapeutic Areas Oncology Neurodegeneration Respiratory Therapeutic Area of Growth Capabilities Pre-Clinical Imaging Translational Imaging Clinical Imaging Pathology Radiochemistry Software and Analytics Resources About Leadership News Events Careers Sites & Partners Contact Us© 2023 Invicro. LLC. All Rights Reserved. | 617.904.2100 | info@invicro.com | This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Notice Page (https://invicro.com/cookie-notice/) If you decline, your information won’t be tracked when you visit this website. A single cookie will be used inwhile you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on . Necessary Necessary Always Enabled Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information. Non Necessary non-necessary Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website. Save &...
Domain Name: INVICRO.COM Registry Domain ID: 1440946639_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.your-server.de Registrar URL: http://www.hetzner.com Updated Date: 2024-04-03T07:21:27Z Creation Date: 2008-04-02T15:55:30Z Registry Expiry Date: 2025-04-02T15:55:30Z Registrar: Hetzner Online GmbH Registrar IANA ID: 828 Registrar Abuse Contact Email: abuse@hetzner.com Registrar Abuse Contact Phone: +49 9831 5050 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.FIRST-NS.DE Name Server: ROBOTNS2.SECOND-NS.DE Name Server: ROBOTNS3.SECOND-NS.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:54:21Z <<<